Distinct immunologic specificity of tumor regression mediated by effector cells isolated from immunized and tumor-bearing mice
- 1 May 1989
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 120 (2) , 419-429
- https://doi.org/10.1016/0008-8749(89)90209-8
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2Science, 1984
- Biological Activity of Recombinant Human Interleukin-2 Produced in Escherichia coliScience, 1984
- The Murine Antitumor Immune Response and Its Therapeutic ManipulationPublished by Elsevier ,1984
- Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells.The Journal of Experimental Medicine, 1983
- "Anomalous" THY-1(+) killer cells in allogeneic and F1-anti-parental mixed leukocyte culture. Relation to natural killer cells and allospecific cytotoxic T lymphocytesThe Journal of Experimental Medicine, 1982
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- Passive Immunotherapy of Cancer in Animals and ManPublished by Elsevier ,1977
- Accurate Identification of Experimental Pulmonary Metastases2JNCI Journal of the National Cancer Institute, 1966